0001209191-17-033755.txt : 20170518 0001209191-17-033755.hdr.sgml : 20170518 20170518201008 ACCESSION NUMBER: 0001209191-17-033755 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170516 FILED AS OF DATE: 20170518 DATE AS OF CHANGE: 20170518 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: QUIDEL CORP /DE/ CENTRAL INDEX KEY: 0000353569 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 942573850 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12544 HIGH BLUFF DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 8585521100 MAIL ADDRESS: STREET 1: 12544 HIGH BLUFF DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: MONOCLONAL ANTIBODIES INC /DE/ DATE OF NAME CHANGE: 19910210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SLACIK CHARLES P CENTRAL INDEX KEY: 0001204660 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-10961 FILM NUMBER: 17856236 MAIL ADDRESS: STREET 1: 250 S. KRAEMER BLVD CITY: BREA STATE: CA ZIP: 92821 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-05-16 0 0000353569 QUIDEL CORP /DE/ QDEL 0001204660 SLACIK CHARLES P 12544 HIGH BLUFF DRIVE SUITE 200 SAN DIEGO CA 92130 1 0 0 0 Common Stock 2017-05-16 4 A 0 1111 0.00 A 1639 D Common Stock 2017-05-17 4 M 0 962 0.00 A 2601 D Restricted Stock Units (Premium) 2017-05-16 4 A 0 222 0.00 A Common Stock 222 222 D Restricted Stock Units (Equity Grant) 2017-05-16 4 A 0 2016 0.00 A Common Stock 2016 2016 D Non-Qualified Stock Options 24.80 2017-05-16 4 A 0 5065 0.00 A 2018-05-16 2027-05-16 Common Stock 5065 5065 D The reporting person has received a fully vested stock payment award for shares of the Company's common stock in lieu of cash payments for certain retainer and Board of Director service-related fees under a 2017 compensation program applicable to participating non-employee directors. Reflects vesting of prior restricted stock units, which were previously reported on a Form 4. Each restricted stock unit represents the right to receive one share of Quidel Corporation common stock. The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a 2017 compensation program applicable to participating non-employee directors. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferral schedule. The restricted stock units vest on the first anniversary date of the grant date, May 16, 2018. Robert J. Bujarski, attorney-in-fact for Charles P. Slacik 2017-05-18